Phase II Study of Temozolomide and Concomitant Whole-Brain Radiotherapy in Patients with Brain Metastases from Solid Tumors

Publisher： Karger

E-ISSN： 2296-5262|30|7|361-366

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.7, 2007-06, pp. : 361-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Whole-Brain Radiotherapy Effective and Safe in Elderly Patients with Brain Metastases?

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 326-329

Karger

Access to resources Recommend Favorite

Reply to comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3244-3245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3243-3244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel risk stratification score for predicting early distant brain failure and salvage whole‐brain radiotherapy after stereotactic radiosurgery for brain metastases

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3836-3843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 35-40

Karger

Access to resources Recommend Favorite